MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Study of Relationship Between Homocysteine, Folic Acid And Vitamin B12 Levels In Serum of Juvenile HD Children.

    A. Kumar, P. Mishra (Delhi, India)

    Objective: Our objective is to estimate the level of Hcy ,vitamin B12 , folic acid with motor and non-motor symptoms in HD patients in school…
  • 2024 International Congress

    Serum urea and clinical outcomes in Huntington’s disease

    O. Makos, J. Badenoch, M. Hartmann, N. Martin, A. Rangel-Cristales, J. Valera-Bermejo, S. Williams, D. van Wamelen (London, United Kingdom)

    Objective: To investigate the relationship between serum urea levels and clinical outcomes in people with Huntington’s disease. Background: Several studies in people with Huntington’s disease…
  • 2024 International Congress

    Epidemiology of Huntington’s Disease in Latin America: A Systematic Review and Meta-analysis.

    A. Medina Escobar, T. Pringsheim, S. Gautreau, J. Rivera-Duarte, G. Amorelli, M. Cornejo-Olivas, M. Rossi (Moncton, Canada)

    Objective: To calculate the pooled prevalence of Huntington's Disease in Latin America. Background: Latin America has played a crucial role in advancing our understanding of…
  • 2024 International Congress

    Racial Disparities in Hospitalization Characteristics among Native Hawaiians, Pacific Islanders and Asian American Subgroups with Restless Legs Syndrome

    L. Terpak, M. Matsunaga, E. Krening, M. Bruno (Honolulu, USA)

    Objective: To determine if patient characteristics differ among Native Hawaiians/Pacific Islanders (NHPI), Asian American (AA) subgroups, and Whites who were hospitalized with Restless Leg Syndrome…
  • 2024 International Congress

    Pitolisant as adjunct therapy for refractory restless legs syndrome

    W. Ondo (Houston, USA)

    Objective: Determine the efficacy and tolerability of pitolisant for adjunct therapy in patients with refractory restless legs syndrome (RLS) Background: RLS treatments include iron, dopaminergics,…
  • 2024 International Congress

    Asymmetric Symptomatic Huntington’s Disease in a Patient with Intermediate Range Trinucleotide Repeats

    D. Palanisamy, L. Hogan, C. Lim, S. Frank (Boston, USA)

    Objective: We report a case of probable symptomatic Huntington’s Disease (HD) in a patient with intermediate range trinucleotide repeats. Background: Huntington’s Disease is an autosomal…
  • 2024 International Congress

    Exploring Correlations between Mutant Huntingtin, NfL, and MRI in Huntington’s Disease: A Multimodal Analysis

    J. Pérez, S. Horta, G. Saura, A. Barba, A. Davi, A. Vázquez, E. Rivas, A. Campolongo, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: This study aims to investigate correlations between mHtt and NfL levels and MRI findings in individuals at different stages of HD, including presymptomatic and…
  • 2024 International Congress

    Clinical and Genetic Characteristics in a Chinese Cohort of Complex Spastic Paraplegia Type 4

    L. Yao, YW. Cao, C. Zhang, XJ. Huang, WT. Tian, L. Cao (shanghai, China)

    Objective: To delineate the genotypic and phenotypic spectrum of patients with complex SPG4 phenotype and further explore genotype-phenotype correlations. Background: Spastic paraplegia type 4 (SPG4),…
  • 2024 International Congress

    Krabbe disease: A systematic review and evidence-based guideline for diagnosis

    WT. Tian, L. Yao, T. Xu, L. Cao (shanghai, China)

    Objective: To summarize and analyze the clinical and genetic profile of patients with Krabbe disease worldwide, and further explore the genotype-phenotype relationships. Background: Krabbe disease…
  • 2024 International Congress

    Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real world practice

    R. Zorowitz, J. Jacinto, S. Ashford, M. Beneteau, P. Maisonobe, C. Hannes, A. Esquenazi (Washington, USA)

    Objective: Describe abobotulinumtoxinA (aboBoNT-A) dosing parameters for the most currently targeted muscles in the routine management of lower limb spasticity. Background: The efficacy and safety…
  • « Previous Page
  • 1
  • …
  • 168
  • 169
  • 170
  • 171
  • 172
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley